Herbalife Ltd.

NYSE:HLF Stock Report

Market Cap: US$1.7b

Herbalife Valuation

Is HLF undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of HLF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: HLF ($16.64) is trading below our estimate of future cash flow value ($24.51)

Significantly Below Future Cash Flow Value: HLF is trading below future cash flow value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for HLF?

Key metric: As HLF is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for HLF. This is calculated by dividing HLF's market cap by their current earnings.
What is HLF's PE Ratio?
PE Ratio5.4x
EarningsUS$320.80m
Market CapUS$1.72b

Price to Earnings Ratio vs Peers

How does HLF's PE Ratio compare to its peers?

The above table shows the PE ratio for HLF vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average22.2x
EPC Edgewell Personal Care
36x60.54%US$904.4m
ODD Oddity Tech
18.5x17.32%US$2.0b
IPAR Interparfums
19.2x3.36%US$3.1b
BRBR BellRing Brands
15.2x6.55%US$3.3b
HLF Herbalife
5.4x-0.85%US$1.7b

Price-To-Earnings vs Peers: HLF is good value based on its Price-To-Earnings Ratio (5.4x) compared to the peer average (22.2x).


Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data


Price to Earnings Ratio vs Industry

How does HLF's PE Ratio compare vs other companies in the US Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
UPXI Upexi
2.3xn/aUS$126.42m
No more companies available in this PE range
HLF 5.4xIndustry Avg. 21.9xNo. of Companies4PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: HLF is good value based on its Price-To-Earnings Ratio (5.4x) compared to the North American Personal Products industry average (21.9x).


Price to Earnings Ratio vs Fair Ratio

What is HLF's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HLF PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio5.4x
Fair PE Ratio12.1x

Price-To-Earnings vs Fair Ratio: HLF is good value based on its Price-To-Earnings Ratio (5.4x) compared to the estimated Fair Price-To-Earnings Ratio (12.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HLF forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$16.64
US$14.00
-15.87%
33.88%US$20.00US$8.00n/a4
Jan ’27US$12.89
US$12.00
-6.90%
31.18%US$17.00US$8.00n/a3
Dec ’26US$12.63
US$9.67
-23.46%
19.51%US$11.00US$7.00n/a3
Nov ’26US$8.00
US$9.33
+16.67%
18.21%US$11.00US$7.00n/a3
Oct ’26US$8.58
US$9.33
+8.78%
18.21%US$11.00US$7.00n/a3
Sep ’26US$9.78
US$9.33
-4.57%
18.21%US$11.00US$7.00n/a3
Aug ’26US$9.14
US$9.00
-1.53%
18.14%US$11.00US$7.00n/a3
Jul ’26US$9.25
US$8.67
-6.31%
19.61%US$11.00US$7.00n/a3
Jun ’26US$7.81
US$8.67
+10.97%
19.61%US$11.00US$7.00n/a3
May ’26US$6.63
US$8.67
+30.72%
19.61%US$11.00US$7.00n/a3
Apr ’26US$8.81
US$10.50
+19.18%
28.97%US$14.00US$7.00n/a4
Mar ’26US$8.30
US$8.63
+3.92%
29.38%US$13.00US$7.00n/a4
Feb ’26US$5.46
US$9.30
+70.33%
28.37%US$13.00US$7.00n/a5
Jan ’26US$6.69
US$9.30
+39.01%
28.37%US$13.00US$7.00US$12.895
Dec ’25US$7.77
US$9.70
+24.84%
24.74%US$13.00US$7.00US$12.635
Nov ’25US$7.83
US$9.70
+23.88%
24.74%US$13.00US$7.00US$8.005
Oct ’25US$7.02
US$13.00
+85.19%
25.28%US$17.00US$8.00US$8.585
Sep ’25US$8.16
US$13.00
+59.31%
25.28%US$17.00US$8.00US$9.785
Aug ’25US$11.23
US$13.00
+15.76%
25.28%US$17.00US$8.00US$9.145
Jul ’25US$10.34
US$12.10
+17.02%
27.46%US$16.00US$8.00US$9.255
Jun ’25US$10.30
US$11.90
+15.53%
28.67%US$16.00US$8.00US$7.815
May ’25US$8.68
US$11.90
+37.10%
28.67%US$16.00US$8.00US$6.635
Apr ’25US$9.11
US$12.50
+37.21%
33.94%US$19.00US$8.00US$8.815
Mar ’25US$8.75
US$13.60
+55.43%
24.87%US$19.00US$10.00US$8.305
Feb ’25US$12.45
US$17.30
+38.96%
29.56%US$24.00US$12.00US$5.465
Jan ’25US$15.26
US$17.30
+13.37%
29.56%US$24.00US$12.00US$6.695
US$14
Fair Value
18.9% overvalued intrinsic discount
4
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/25 02:36
End of Day Share Price 2026/01/23 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Herbalife Ltd. is covered by 16 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John StaszakArgus Research Company
Meredith AdlerBarclays
Brian WangBarclays